Episodes 166-180 of 372
The Benefits of TZDs for Early Type 2 Diabetes
Diabetes DiscourseThe Benefits of TZDs for Early Type 2 Diabetes
Oral Agents for Diabetes: What to Choose and When
Diabetes DiscourseOral Agents for Diabetes: What to Choose and When
Report From Capitol Hill with AMA Board Chair Dr. Rebecca Patchin
Second Opinion LIVE!Report From Capitol Hill with AMA Board Chair Dr. Rebecca Patchin
The Battle Continues Against Pharmacological Cheating in Sports
Focus on Sports MedicineThe Battle Continues Against Pharmacological Cheating in Sports
Multiple Choice: Customizing Insulin Therapy
Diabetes DiscourseMultiple Choice: Customizing Insulin Therapy
- advertisement
As Prescribed: Meeting the Challenges of Medication Adherence
Heart MattersAs Prescribed: Meeting the Challenges of Medication Adherence
In-Office Drug Testing for Retinal Conditions
Revealing RetinaIn-Office Drug Testing for Retinal Conditions
The Potential of Immunotherapy in Type 1 Diabetes
Diabetes DiscourseThe Potential of Immunotherapy in Type 1 Diabetes
Interventions Targeting Impaired Glucose Tolerance
Diabetes DiscourseInterventions Targeting Impaired Glucose Tolerance
- advertisement
The ARBITER 6-HALTS Trial: Clinical Implications
Heart MattersThe ARBITER 6-HALTS Trial: Clinical Implications
Are Out-of-State Provider Licensing Laws Due for a Change?
Second Opinion LIVE!Are Out-of-State Provider Licensing Laws Due for a Change?
How Will Pharmacogenomics Play a Role in Diabetes Therapy?
Diabetes DiscourseHow Will Pharmacogenomics Play a Role in Diabetes Therapy?
